We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZNTL icon
2326
Zentalis Pharmaceuticals
ZNTL
$297M
$130K ﹤0.01%
6,021
-1,619
-21% -$44.3K
CFB
2327
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$130K ﹤0.01%
9,960
+8,970
+906% +$122K
CYBE
2328
DELISTED
Cyberoptics Corp
CYBE
$130K ﹤0.01%
2,413
-636
-21% -$29.7K
BTG icon
2329
B2Gold
BTG
$6.7B
$129K ﹤0.01%
40,041
+30,418
+316% +$100K
BVS icon
2330
Bioventus
BVS
$1.17B
$129K ﹤0.01%
18,436
+4,060
+28% +$31.8K
CRMD icon
2331
CorMedix
CRMD
$639M
$129K ﹤0.01%
+45,696
New +$190K
KOD icon
2332
Kodiak Sciences
KOD
$2.5B
$129K ﹤0.01%
16,641
+12,461
+298% +$121K
KTB icon
2333
Kontoor Brands
KTB
$4.65B
$129K ﹤0.01%
3,844
+1,674
+77% +$62K
LI icon
2334
Li Auto
LI
$12B
$129K ﹤0.01%
5,617
-18,779
-77% -$585K
LYFT icon
2335
Lyft
LYFT
$6.48B
$129K ﹤0.01%
9,816
-56,168
-85% -$864K
ROCK icon
2336
Gibraltar Industries
ROCK
$1.45B
$129K ﹤0.01%
3,152
+1,083
+52% +$46.2K
SVC
2337
Service Properties Trust
SVC
$1.06B
$129K ﹤0.01%
4,957
+3,223
+186% +$107K
VIR icon
2338
Vir Biotechnology
VIR
$1.52B
$129K ﹤0.01%
6,697
-19,975
-75% -$508K
MGI
2339
DELISTED
MoneyGram International, Inc. New
MGI
$129K ﹤0.01%
12,402
+9,243
+293% +$95.3K
AVTR icon
2340
Avantor
AVTR
$9.37B
$128K ﹤0.01%
6,539
-9,712
-60% -$260K
CIG icon
2341
CEMIG Preferred Shares
CIG
$5.58B
$128K ﹤0.01%
82,167
+12,583
+18% +$21.7K
DIV icon
2342
Global X SuperDividend US ETF
DIV
$780M
$128K ﹤0.01%
7,277
+482
+7% +$9.56K
FCF icon
2343
First Commonwealth Financial
FCF
$2.19B
$128K ﹤0.01%
9,955
+7,001
+237% +$98.1K
FLGT icon
2344
Fulgent Genetics
FLGT
$513M
$128K ﹤0.01%
3,369
+1,765
+110% +$88.5K
KEX icon
2345
Kirby Corp
KEX
$7.26B
$128K ﹤0.01%
2,114
-1,588
-43% -$102K
MCS icon
2346
Marcus Corp
MCS
$929M
$128K ﹤0.01%
9,185
+3,009
+49% +$48.4K
NE icon
2347
Noble Corp
NE
$7.07B
$128K ﹤0.01%
4,334
+2,870
+196% +$84.8K
OXM icon
2348
Oxford Industries
OXM
$542M
$128K ﹤0.01%
1,421
+936
+193% +$90.6K
PRAA icon
2349
PRA Group
PRAA
$762M
$128K ﹤0.01%
3,875
-318
-8% -$11.8K
RGP icon
2350
Resources Connection
RGP
$145M
$128K ﹤0.01%
7,085
+4,986
+238% +$99.9K
92 93
94
95 96

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.